BridgeBio Oncology Therapeutics Inc has recorded no insider trading activity within the past ninety days. The most recent transactions occurred on February 13, 2024, when CEO and Chairperson Chen Bihua executed multiple significant share purchases. These historical acquisitions represent the final documented internal movements for the firm.